The results of our present study demonstrate distinct beneficial effects of IL-6 knockdown in combination with cisplatin treatment, and provide a theoretical base for applying siRNA techniques in the treatment of laryngeal cancer. Here, IL6 is linked to laryngeal carcinoma.